A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability.

Up to now, out of approximately 20 antisense oligodeoxyribonucleotides (as ODN) selected and tested against a given target gene, only one species shows substantial suppression of target gene expression. In part, this seems to be related to the general assumption that the structures of local target sequences or antisense nucleic acids are unfavorable for efficient annealing. Experimental approaches to find effective as ODN are extremely expensive when including a large number of antisense species and when considering their moderate success. Here, we make use of a systematic alignment of computer-predicted secondary structures of local sequence stretches of the target RNA and of semi-empirical rules to identify favorable local target sequences and, hence, to design more effective as ODN. The intercellular adhesion molecule 1 (ICAM-1) gene was chosen as a target because it had been shown earlier to be sensitive to antisense-mediated gene suppression. By applying the protocol described here, 10 ICAM-1-directed as ODN species were found that showed substantially improved inhibition of target gene expression in the endothelial cell line ECV304 when compared with the most effective published as ODN. Further, 17 out of 34 antisense species (50%) selected on the theoretical basis described here showed significant (>50%) inhibition of ICAM-1 expression in mammalian cells.

[1]  G. Sczakiel,et al.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. , 1993, Nucleic acids research.

[2]  H. Soreq,et al.  Probing accessible sites for ribozymes on human acetylcholinesterase RNA. , 1997, RNA.

[3]  W. James,et al.  Computational approaches to the identification of ribozyme target sites. , 1997, Methods in molecular biology.

[4]  O Ritter,et al.  X-HUSAR, an X-based graphical interface for the analysis of genomic sequences. , 1995, Computer methods and programs in biomedicine.

[5]  E. Jankowsky,et al.  Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators. , 1996, Biochemistry.

[6]  P. Romby,et al.  Implications of RNA structure on the annealing of a potent antisense RNA directed against the human immunodeficiency virus type 1. , 1997, Biochemistry.

[7]  C. Bernstein,et al.  β2 Integrin/ICAM Expression in Crohn's Disease☆ , 1998 .

[8]  J. Voorhees,et al.  Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. , 1989, Journal of the American Academy of Dermatology.

[9]  P. Schwille,et al.  Quantitative hybridization kinetics of DNA probes to RNA in solution followed by diffusional fluorescence correlation analysis. , 1996, Biochemistry.

[10]  C. Bennett,et al.  Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. , 1994, Journal of immunology.

[11]  Michael Loran Dustin,et al.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. , 1986, Journal of immunology.

[12]  Randall R. Sakai,et al.  Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries , 1998, Nature Biotechnology.

[13]  K. Moelling,et al.  Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences. , 1994, Nucleic acids research.

[14]  K. Stecker,et al.  An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. , 1997, The Journal of pharmacology and experimental therapeutics.

[15]  P. Schuster,et al.  Statistics of RNA secondary structures , 1993, Biopolymers.

[16]  Yedy Israel,et al.  Tetranucleotide GGGA Motif in Primary RNA Transcripts , 1998, The Journal of Biological Chemistry.

[17]  J. Tomassini,et al.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Southern,et al.  Selecting effective antisense reagents on combinatorial oligonucleotide arrays , 1997, Nature Biotechnology.

[19]  J. Rossi,et al.  Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. , 1998, Nucleic acids research.

[20]  D. Ecker,et al.  Implication of RNA structure on antisense oligonucleotide hybridization kinetics. , 1992, Biochemistry.

[21]  G Sczakiel,et al.  Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. , 1993, Antisense research and development.

[22]  V. Patzel,et al.  Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells , 1998, Nature Biotechnology.

[23]  H. Blöcker,et al.  Predicting DNA duplex stability from the base sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[24]  O. Uhlenbeck.  Tetraloops and RNA folding , 1990, Nature.

[25]  Antisense ICAM-1 oligonucleotides block allograft rejection in rats. , 1997, Transplantation proceedings.

[26]  Doriano Fabbro,et al.  Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase , 1996, Nature Medicine.

[27]  W D Wilson,et al.  Sequence specific thermodynamic and structural properties for DNA.RNA duplexes. , 1994, Biochemistry.

[28]  S. Freier,et al.  Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. , 1991, The Journal of biological chemistry.

[29]  R. Hanecak,et al.  Combinatorial Screening and Rational Optimization for Hybridization to Folded Hepatitis C Virus RNA of Oligonucleotides with Biological Antisense Activity* , 1997, The Journal of Biological Chemistry.